AstraZeneca PLC is 48.7x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $5.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RYTM | AZN |
|---|---|---|
| Market cap | $5.87 B | $286.27 B |
| US-listed rank | #1281 | #45 |
| Revenue (latest FY) | $189.76M | - |
| Net income (latest FY) | -$196.54K | - |
| Net margin | -0.1% | - |
| SEC filings | 799 | 1,004 |
AstraZeneca PLC is 48.7x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $5.87 B).
Full pages: RHYTHM PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.